129 related articles for article (PubMed ID: 3922198)
1. The brain octopamine and phenylethanolamine content in rats in thioacetamide-induced hepatogenic encephalopathy.
Hilgier W; Zitting A; Albrecht J
Acta Neurol Scand; 1985 Mar; 71(3):195-8. PubMed ID: 3922198
[TBL] [Abstract][Full Text] [Related]
2. Age variation in the increase of hypothalamic and brain stem contents of phenylethanolamine m-octopamine and p-octopamine in spontaneously hypertensive rats (SH Kyoto).
David JC
Experientia; 1979 Nov; 35(11):1483-4. PubMed ID: 389655
[TBL] [Abstract][Full Text] [Related]
3. Brain carbonic anhydrase activity in rats in experimental hepatogenic encephalopathy.
Albrecht J; Hilgier W
Neurosci Lett; 1984 Mar; 45(1):7-10. PubMed ID: 6427713
[TBL] [Abstract][Full Text] [Related]
4. Changes in the metabolism and binding of GABA in the rat brain in thioacetamide-induced hepatogenic encephalopathy.
Wysmyk-Cybula U; Dabrowiecki Z; Albrecht J
Biomed Biochim Acta; 1986; 45(3):413-9. PubMed ID: 3707558
[TBL] [Abstract][Full Text] [Related]
5. Brain contents of phenylethanolamine, m-octopamine and p-octopamine in the Roman strains of rats.
David JC; Delacour J
Brain Res; 1980 Aug; 195(1):231-5. PubMed ID: 6772269
[No Abstract] [Full Text] [Related]
6. Changes in arterial and cerebral venous blood gases, cerebral blood flow and cerebral oxygen consumption at different stages of thioacetamide-induced hepatogenic encephalopathy in rat.
Pluta R; Albrecht J
Resuscitation; 1986 Nov; 14(3):135-9. PubMed ID: 3027806
[TBL] [Abstract][Full Text] [Related]
7. Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission.
Zimmermann C; Ferenci P; Pifl C; Yurdaydin C; Ebner J; Lassmann H; Roth E; Hörtnagl H
Hepatology; 1989 Apr; 9(4):594-601. PubMed ID: 2564368
[TBL] [Abstract][Full Text] [Related]
8. Oxidation of phenylethanolamine and octopamine by type A and type B monoamine oxidase. Effect of substrate concentration.
Suzuki O; Katsumata Y; Oya M; Matsumoto T
Biochem Pharmacol; 1979 Aug; 28(15):2327-32. PubMed ID: 387041
[No Abstract] [Full Text] [Related]
9. Influence of phenylethanolamine on octopamine plasma determination in hepatic encephalopathy.
Capocaccia L; Cangiano C; Cascino A; Calcaterra V; Cardelli P; Rossi Fanelli F
Clin Chim Acta; 1979 May; 93(3):371-6. PubMed ID: 376188
[TBL] [Abstract][Full Text] [Related]
10. Behavioral and biochemical characterization of rats treated chronically with thioacetamide: proposal of an animal model for hepatic encephalopathy associated with cirrhosis.
Kawai H; Ishibashi T; Kudo N; Kawashima Y; Mitsumoto A
J Toxicol Sci; 2012; 37(6):1165-75. PubMed ID: 23208432
[TBL] [Abstract][Full Text] [Related]
11. The concentration in brain of octopamine and tyramine after portal-systemic bypass in rats: neuroamine concentrations determined simultaneously by methane chemical ionization gas chromatography mass spectrometry.
Meredith CG; Duffield PH; Dougan DF; Duffield AM; Wade DN
Life Sci; 1986 May; 38(18):1701-5. PubMed ID: 3702599
[TBL] [Abstract][Full Text] [Related]
12. [Thioacetamide-induced hepatic encephalopathy in the rat. III Ammonia level and its metabolic substrates in the brain].
Hilgier W
Neuropatol Pol; 1983; 21(4):511-8. PubMed ID: 6142431
[No Abstract] [Full Text] [Related]
13. Plasma phenylethanolamine in hepatic encephalopathy.
Cangiano C; Rossi-Fanelli F; Bozzi A; Calcaterra V; Cascino A; Capocaccia L
Eur J Clin Invest; 1978 Jun; 8(3):183-4. PubMed ID: 99315
[TBL] [Abstract][Full Text] [Related]
14. Protective role of chrysin on thioacetamide-induced hepatic encephalopathy in rats.
El-Marasy SA; El Awdan SA; Abd-Elsalam RM
Chem Biol Interact; 2019 Feb; 299():111-119. PubMed ID: 30500344
[TBL] [Abstract][Full Text] [Related]
15. Kynurenic acid synthesis in cerebral cortical slices of rats with progressing symptoms of thioacetamide-induced hepatic encephalopathy.
Saran T; Hilgier W; Urbańska EM; Turski WA; Albrecht J
J Neurosci Res; 2004 Feb; 75(3):436-40. PubMed ID: 14743457
[TBL] [Abstract][Full Text] [Related]
16. Effects of aging on p- and m-octopamine, catecholamines, and their metabolizing enzymes in the rat.
David JC; Coulon JF; Cavoy A; Delacour J
J Neurochem; 1989 Jul; 53(1):149-54. PubMed ID: 2566654
[TBL] [Abstract][Full Text] [Related]
17. Effects of caffeic acid phenethyl ester on thioacetamide-induced hepatic encephalopathy in rats.
Fadillioglu E; Gursul C; Iraz M
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1440-5. PubMed ID: 20708059
[TBL] [Abstract][Full Text] [Related]
18. A selective radioenzymatic assay for the determination of octopamine and phenylethanolamine in plasma and cerebrospinal fluid. Preliminary results in human and experimental hepatic encephalopathy.
Rossi-Fanelli F; Cangiano C; Smith AR; Bozzi A; James JH; Kay LA; Perelle BA; Capocaccia L; Fischer JE
Ital J Biochem; 1978; 27(6):450-65. PubMed ID: 385550
[TBL] [Abstract][Full Text] [Related]
19. Activation of arginine metabolism to glutamate in rat brain synaptosomes in thioacetamide-induced hepatic encephalopathy: an adaptative response?
Albrecht J; Hilgier W; Rafałowska U
J Neurosci Res; 1990 Jan; 25(1):125-30. PubMed ID: 1969494
[TBL] [Abstract][Full Text] [Related]
20. Decreased glucose utilization in discrete brain regions of rat in thioacetamide-induced hepatic encephalopathy as measured with [3H]-deoxyglucose.
Hilgier W; Benveniste H; Diemer NH; Albrecht J
Acta Neurol Scand; 1991 Jun; 83(6):353-5. PubMed ID: 1887755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
